← Leaderboards
Nicole R Murray
University Of Texas Medical Br Galveston
$3,830,138
Attributed
$4,073,992
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $485.1K · FY2005–15$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$4,073,992 · 6
By mechanism
R01$3,070,373 · 2
R21$702,381 · 2
R03$301,238 · 2
Top collaborators
- E Aubrey Thompson2 shared
- Michael Bradley Wallace2 shared
Most similar at University Of Texas Medical Br Galveston
Same institution · by research overlap
- Alan P Fields$16,541,191
- Randall J Urban$29,729,784
- E Aubrey Thompson$2,793,172
- James Simeon Goodwin$25,964,887
Others in their field
Top investigators on “Carcinogenesis”
- Thomas James Lynch · Fred Hutchinson Cancer Center$52,622,533
- John Anthony Baron · Dartmouth College$42,903,133
- Judith Cheryl Gasson · University Of California Los Angeles$27,647,316
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$27,566,264
- Frank Louis Meyskens · University Of California Irvine$27,314,067
- Paul F Lambert · University Of Wisconsin Madison$25,295,170
Research focus
CarcinogenesisPancreatic NeoplasmMalignant Neoplasm Of PancreasPlayTumorCancer PatientSignal PathwayGrowthResistanceProtein Kinase C IotaSignal TransductionDesignOncogenicBaseMaintenancePancreasPancreatic Ductal AdenocarcinomaGeneticIn VitroIn VivoLaboratory MouseMediatingCellsMalignant Neoplasms
Grant awards (20)
Role of PKC iota in metaplasia and initiation of pancreatic cancer$321,625
R01 · FY2015 · CA · contact PI
Role of PKC iota in metaplasia and initiation of pancreatic cancer$311,976
R01 · FY2014 · CA · contact PI
Role of PKC iota in metaplasia and initiation of pancreatic cancer$302,328
R01 · FY2013 · CA · contact PI
Role of PKC iota in metaplasia and initiation of pancreatic cancer$321,625
R01 · FY2012 · CA · contact PI
Role of PKC iota in metaplasia and initiation of pancreatic cancer$321,625
R01 · FY2011 · CA · contact PI
Fusion gene mutations as biomarkers of pancreatic cancer lymph node metastases$163,506
R21 · FY2011 · CA
Fusion gene mutations as biomarkers of pancreatic cancer lymph node metastases$202,275
R21 · FY2010 · CA
Role of atypical PKCs in Pancreatic Tumor Growth and Metastasis$76,500
R03 · FY2010 · CA · contact PI
Role of atypical PKCs in Pancreatic Tumor Growth and Metastasis$76,500
R03 · FY2009 · CA · contact PI
Role of PKC iota in Pancreatic Carcinogenesis$183,600
R21 · FY2008 · CA · contact PI
Role of PKC iota in Pancreatic Carcinogenesis$153,000
R21 · FY2007 · CA · contact PI
Role of Protein Kinase C Iota in Colon Carcinogenesis$253,821
R01 · FY2006 · CA · contact PI
PKC Beta II: A target for colon cancer chemoprevention$73,238
R03 · FY2006 · CA · contact PI
Role of Protein Kinase C Iota in Colon Carcinogenesis$267,000
R01 · FY2005 · CA
PKC Beta II: A target for colon cancer chemoprevention$75,000
R03 · FY2005 · CA
Role of Protein Kinase C Iota in Colon Carcinogenesis$69,000
R01 · FY2005 · CA
Role of Protein Kinase C Iota in Colon Carcinogenesis$267,000
R01 · FY2004 · CA
Role of Protein Kinase C Iota in Colon Carcinogenesis$69,000
R01 · FY2004 · CA
Role of Protein Kinase C Iota in Colon Carcinogenesis$267,000
R01 · FY2003 · CA
Role of Protein Kinase C Iota in Colon Carcinogenesis$298,373
R01 · FY2002 · CA